NVCR
$134.41
Novocure Ltd Ord Sh
$2.05
1.55%
NVCR
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $0.08
Revenue:  $121.83 Mil
Thursday
Jan 28
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when NVCR reports earnings?
Beat
Meet
Miss

Where is NVCR's stock price going from here?
Up
Flat
Down
Stock chart of NVCR
Analysts
Summary of analysts' recommendations for NVCR
Score
Grade
Pivots
Resistance
$145.31
$140.57
$136.47

$131.73

Support
$127.63
$122.89
$118.79
Tweet
Growth
Description
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.